相关实验视频
Updated: Feb 10, 2026

08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
41.3K
在喘的3D呼吸模式中,微RNA介导的变化有助于佐[a]皮林毒性
Reese M Valdez1,2, Yvonne Chang1,2, Jamie M Pennington1
1Environmental and Molecular Toxicology Department, Oregon State University, Corvallis, OR, USA.
Current research in toxicology
|February 9, 2026
概括
这项研究揭示了微RNA (miRNA) 在喘模型中如何调节细胞对化学污染物[a]烯 (BAP) 的反应. 喘肺细胞表现出独特的miRNA向丰富,影响细胞周期和信号通路.
科学领域:
- 环境毒理学环境毒理学
- 分子生物学分子生物学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 像炎症这样的非化学压力因素可能会加剧化学物质暴露的结果.
- 喘涉及炎症和独特的细胞对污染物,如[a]皮林 (BAP) 的反应.
研究的目的:
- 在正常和IL-13诱导的喘人类支气管上皮细胞 (HBECs) 中研究BAP暴露后的微RNA (miRNA) 和mRNA调节.
- 了解miRNAs如何调节BAP毒性在基于炎症的呼吸道疾病模型中.
主要方法:
- 主要的3DHBECs与IL-13或没有IL-13进行培养,以创建正常和喘表型.
- 用BAP治疗细胞,并分析差异表达的miRNA和mRNA.
- 预测miRNA目标可以评估每个表型的功能后果.
主要成果:
- 在正常和喘HBEC中,BAP暴露改变了miRNA和mRNA的表达.
- 暴露于BAP的喘HBEC患者显示出独特的miRNA点丰富.
- 这些目标参与了细胞周期上调和下调的NOTCH,WNT和 Hedgehog信号通路.
结论:
- 这项研究提供了第一个关于miRNA在呼吸道炎症模型中调节化学毒性的作用的见解.
- miRNAs是喘肺细胞对BAP细胞反应的关键调节者.
- 了解这些miRNA介导的途径对于解决化学暴露的喘患者的健康结果至关重要.
相关概念视频
MicroRNAs
24.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K
MicroRNAs
4.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.0K
Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-III: Symptoms and Complications
3.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.4K
Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Binet's Contribution to Measures of Intelligence
1.8K
Alfred Binet, along with his student Théophile Simon, was tasked by the French Ministry of Education in 1904 to create a method for identifying students who struggled to learn through conventional classroom instruction. This initiative aimed to address overcrowding by placing such students in specialized schools. Binet and Simon developed an intelligence test comprising 30 tasks, ranging from simple commands, like touching one's nose or ear, to more complex tasks, such as drawing...
1.8K

